SEYİTLER KİMYA SANAYİ A.Ş. Logo

SEYİTLER KİMYA SANAYİ A.Ş.

SEYKM | IS

Overview

Corporate Details

ISIN(s):
TRESEYT00011 (+2 more)
LEI:
789000QODBWOP1OPEQ85
Country:
Türkiye
Address:
Turgutlu 1. OSB 2007 Cad. No:5-7 Turgutlu, 45400 MANİSA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1991, Seyitler Kimya Sanayi A.Ş. is a leading manufacturer in the healthcare sector. The company specializes in producing a range of medical supplies, including medical adhesive tapes, wound dressings, first aid plasters, and capsicum rheumatism plasters. With a focus on quality management and continuous research and development, Seyitler Kimya aims to serve the healthcare industry by providing reliable products. The company's goal is to be a preferred manufacturer both in its domestic market and globally, driven by a commitment to customer satisfaction and high production standards.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for SEYİTLER KİMYA SANAYİ A.Ş.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 17:11
Regulatory News Service
Participation Finance Principles Information Form
Turkish 52.6 KB
2025-08-11 17:12
Regulatory News Service
30.06.2025 Sorumluluk Beyanı Hk.
Turkish 21.6 KB
2025-08-11 17:12
Regulatory News Service
30.06.2025 Faaliyet Raporu Hk.
Turkish 1.4 MB
2025-08-11 17:12
Regulatory News Service
30.06.2025 Faaliyet Raporu Hk.
Turkish 10.9 KB
2025-08-11 17:12
Regulatory News Service
Financial Report
Turkish 1.9 MB
2025-08-11 17:12
Regulatory News Service
Financial Report
Turkish 2.5 MB
2025-08-04 17:15
Regulatory News Service
Company General Info Form
Turkish 3.7 KB
2025-06-24 17:05
Legal Proceedings Report
Tazminat Davası Hk
English 45.6 KB
2025-06-24 17:04
Legal Proceedings Report
Marka İhlal Davası Hk
Turkish 46.9 KB
2025-06-02 14:12
Board/Management Information
Kurumsal Yönetim Komitesi üyesi güncellemesi hk
Turkish 52.5 KB
2025-06-02 13:39
Governance Information
Company General Info Form
Turkish 3.7 KB
2025-05-26 17:16
Share Issue/Capital Change
Tahsisli Sermaye Artırımı Başvurusu Süreç İptali Hk.
Turkish 2.8 KB
2025-05-26 17:11
Share Issue/Capital Change
Tahsisli Sermaye Artırımı Başvurusunun Geri Çekilmesi Hk
Turkish 12.4 KB
2025-05-14 07:53
Legal Proceedings Report
Marka İhlal Davası Hk
Turkish 47.1 KB
2025-05-14 07:52
Legal Proceedings Report
Tazminat Davası Hk
English 46.0 KB

Automate Your Workflow. Get a real-time feed of all SEYİTLER KİMYA SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SEYİTLER KİMYA SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Fagron N.V. Logo
Supplies compounding ingredients and solutions for personalized medicine to healthcare professionals.
Belgium FAGR
Farmak Logo
Develops and exports a portfolio of 450+ medicines to more than 50 countries globally.
Ukraine FARM
Farmsintez ao Logo
Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.
Russian Federation LIFE
Fine Foods & Pharmaceuticals Ntm Logo
CDMO for oral solid forms for pharma, nutraceutical, cosmetic & medical device industries.
Italy FF
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Friulchem Logo Italy FCM
Fuji Pharma Co.,Ltd. Logo Japan 4554
FunPep Company Limited Logo Japan 4881
Fuso Pharmaceutical Industries,Ltd. Logo Japan 4538
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG